Back pain is a very common sickness affecting around 8 out of 10 people at some point in their lifetime. In general, the spinal cord has a difficult job in every human body as it should give the best support to your upper body weight, and still, it is also able to twist and bend in any direction. So, a very big strain is placed on the lower back specifically among the individuals who are underactive or do a lot of sitting. There are so many conditions available causing back pain and some of them are emotional tension and pregnancy which are very natural occurrences. But there are also a few factors available to make problems to your back including athletic injuries, physical trauma, being overweight, and poor physical fitness.
Causes of back pain
The following are the major causes of back pain in humans such as,
- Improper or overuse of the back will surely cause back strain or painful muscle spasms. For example, tearing or stretching of the muscles.
- Ruptured or slipped discs may give you heavy pain when the discs give pressure to the nerves of the spinal cord. The pain can emit during the legs and also back.
- Weak belly muscles will also cause back strain such as torn or stretched ligaments instead of muscles because of the inappropriate positioning of the spine.
- Soft or strain tissue damage is secondary to injury.
- Improper posture can cause back sprain or strain because of improper lifting, bending, standing, or
The European Commission President Ursula von der Leyen revealed that the vaccines from the drugmaker of the U.S. and its German partner BioNTech would be successfully delivered over the period from 2021 to 2023. This news is published after his visit to vaccine plant of Pfizer in Puurs, Belgium.
The latest agreements
The European Commission wants to seal the largest vaccine deliver deal in the world within days and buy up to 1.8 billion quantity of Covid-19 vaccine of Pfizer for the next three years mainly as a debate rages over the complete unfair access to shots for the poorest people of the world. This agreement would be sufficient for inoculating the 450 million European population for 2 years and the long-term supplies. This is the 3rd contract signed by the bloc with the 2 companies which agreed to supply 600 million doses of the 2-dose vaccine this year as per the 2 previous contracts.
Brussels has an aim to inoculate at least seventy percentages of the European adults within July. This move is because of the Commission looks at sever ties with the popular AstraZeneca subsequent to the drugmaker slashed its delivery targets because of the production problems. The commission was deciding whether to take any legal action in opposition to the British-Swedish pharmaceutical company. Though the supply deal was agreed in principle, there was a requirement at both sides to iron out final terms.
Vaccines for everyone
The overall efforts of the Commission will secure the …